USANA HEALTH SCIENCES INC (USNA) Fundamental Analysis & Valuation

NYSE:USNA • US90328M1071

Current stock price

18.51 USD
+0.34 (+1.87%)
At close:
18.51 USD
0 (0%)
After Hours:

This USNA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. USNA Profitability Analysis

1.1 Basic Checks

  • USNA had positive earnings in the past year.
  • USNA had a positive operating cash flow in the past year.
  • USNA had positive earnings in each of the past 5 years.
  • USNA had a positive operating cash flow in each of the past 5 years.
USNA Yearly Net Income VS EBIT VS OCF VS FCFUSNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.45%, USNA is in line with its industry, outperforming 59.46% of the companies in the same industry.
  • USNA has a Return On Equity of 2.02%. This is in the better half of the industry: USNA outperforms 64.86% of its industry peers.
  • The Return On Invested Capital of USNA (6.54%) is better than 64.86% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for USNA is in line with the industry average of 10.52%.
Industry RankSector Rank
ROA 1.45%
ROE 2.02%
ROIC 6.54%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
USNA Yearly ROA, ROE, ROICUSNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • USNA's Profit Margin of 1.16% is in line compared to the rest of the industry. USNA outperforms 59.46% of its industry peers.
  • In the last couple of years the Profit Margin of USNA has declined.
  • With a decent Operating Margin value of 5.50%, USNA is doing good in the industry, outperforming 62.16% of the companies in the same industry.
  • USNA's Operating Margin has declined in the last couple of years.
  • USNA has a Gross Margin of 78.29%. This is amongst the best in the industry. USNA outperforms 94.59% of its industry peers.
  • In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
Industry RankSector Rank
OM 5.5%
PM (TTM) 1.16%
GM 78.29%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
USNA Yearly Profit, Operating, Gross MarginsUSNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. USNA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so USNA is still creating some value.
  • USNA has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, USNA has less shares outstanding
  • The debt/assets ratio for USNA has been reduced compared to a year ago.
USNA Yearly Shares OutstandingUSNA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
USNA Yearly Total Debt VS Total AssetsUSNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • USNA has an Altman-Z score of 3.58. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
  • USNA has a better Altman-Z score (3.58) than 78.38% of its industry peers.
  • There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.64
Altman-Z 3.58
ROIC/WACC0.76
WACC8.63%
USNA Yearly LT Debt VS Equity VS FCFUSNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • USNA has a Current Ratio of 2.24. This indicates that USNA is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.24, USNA is in the better half of the industry, outperforming 64.86% of the companies in the same industry.
  • USNA has a Quick Ratio of 1.45. This is a normal value and indicates that USNA is financially healthy and should not expect problems in meeting its short term obligations.
  • USNA has a Quick ratio of 1.45. This is in the better half of the industry: USNA outperforms 64.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.45
USNA Yearly Current Assets VS Current LiabilitesUSNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. USNA Growth Analysis

3.1 Past

  • USNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.15%.
  • USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.00% yearly.
  • Looking at the last year, USNA shows a quite strong growth in Revenue. The Revenue has grown by 8.28% in the last year.
  • USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.00% yearly.
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%

3.2 Future

  • Based on estimates for the next years, USNA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.31% on average per year.
  • Based on estimates for the next years, USNA will show a small growth in Revenue. The Revenue will grow by 4.02% on average per year.
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USNA Yearly Revenue VS EstimatesUSNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
USNA Yearly EPS VS EstimatesUSNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. USNA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.64, the valuation of USNA can be described as very reasonable.
  • Based on the Price/Earnings ratio, USNA is valued cheaper than 86.49% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.34, USNA is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.07 indicates a reasonable valuation of USNA.
  • USNA's Price/Forward Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 81.08% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.18. USNA is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.64
Fwd PE 9.07
USNA Price Earnings VS Forward Price EarningsUSNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • USNA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. USNA is cheaper than 100.00% of the companies in the same industry.
  • USNA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 40.08
EV/EBITDA 2.37
USNA Per share dataUSNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • USNA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of USNA may justify a higher PE ratio.
  • USNA's earnings are expected to grow with 21.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.54
PEG (5Y)N/A
EPS Next 2Y21.31%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USNA Dividend Analysis

5.1 Amount

  • No dividends for USNA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

USNA Fundamentals: All Metrics, Ratios and Statistics

USANA HEALTH SCIENCES INC

NYSE:USNA (4/14/2026, 8:04:00 PM)

After market: 18.51 0 (0%)

18.51

+0.34 (+1.87%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-17
Earnings (Next)04-28
Inst Owners57.94%
Inst Owner Change-0.02%
Ins Owners0.74%
Ins Owner Change0.54%
Market Cap341.69M
Revenue(TTM)925.26M
Net Income(TTM)10.76M
Analysts43.33
Price Target39.78 (114.91%)
Short Float %4.89%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-43.91%
Min EPS beat(2)-131.29%
Max EPS beat(2)43.47%
EPS beat(4)3
Avg EPS beat(4)-12.81%
Min EPS beat(4)-131.29%
Max EPS beat(4)43.47%
EPS beat(8)6
Avg EPS beat(8)-0.77%
EPS beat(12)9
Avg EPS beat(12)8.1%
EPS beat(16)10
Avg EPS beat(16)9.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.12%
Min Revenue beat(2)-6.39%
Max Revenue beat(2)-1.86%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)2.74%
Revenue beat(8)3
Avg Revenue beat(8)-2.04%
Revenue beat(12)6
Avg Revenue beat(12)-1.41%
Revenue beat(16)8
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10%
EPS NY rev (1m)0%
EPS NY rev (3m)5.26%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)7.96%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)4.1%
Valuation
Industry RankSector Rank
PE 9.64
Fwd PE 9.07
P/S 0.37
P/FCF 40.08
P/OCF 15.29
P/B 0.64
P/tB 1.3
EV/EBITDA 2.37
EPS(TTM)1.92
EY10.37%
EPS(NY)2.04
Fwd EY11.02%
FCF(TTM)0.46
FCFY2.5%
OCF(TTM)1.21
OCFY6.54%
SpS50.12
BVpS28.88
TBVpS14.19
PEG (NY)1.54
PEG (5Y)N/A
Graham Number35.32
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 2.02%
ROCE 8.28%
ROIC 6.54%
ROICexc 8.81%
ROICexgc 21.74%
OM 5.5%
PM (TTM) 1.16%
GM 78.29%
FCFM 0.92%
ROA(3y)5.72%
ROA(5y)9.79%
ROE(3y)7.58%
ROE(5y)13.64%
ROIC(3y)9.82%
ROIC(5y)16.1%
ROICexc(3y)20.39%
ROICexc(5y)37.76%
ROICexgc(3y)38.56%
ROICexgc(5y)58.83%
ROCE(3y)12.43%
ROCE(5y)20.38%
ROICexgc growth 3Y-33.6%
ROICexgc growth 5Y-29.38%
ROICexc growth 3Y-44.57%
ROICexc growth 5Y-36.69%
OM growth 3Y-20.1%
OM growth 5Y-18.78%
PM growth 3Y-44.89%
PM growth 5Y-36.19%
GM growth 3Y-0.96%
GM growth 5Y-0.82%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.64
Debt/EBITDA 0
Cap/Depr 42.45%
Cap/Sales 1.49%
Interest Coverage 76.71
Cash Conversion 26.79%
Profit Quality 79.24%
Current Ratio 2.24
Quick Ratio 1.45
Altman-Z 3.58
F-Score7
WACC8.63%
ROIC/WACC0.76
Cap/Depr(3y)541.47%
Cap/Depr(5y)369.8%
Cap/Sales(3y)9.35%
Cap/Sales(5y)6.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.15%
EPS 3Y-18.83%
EPS 5Y-20%
EPS Q2Q%-6.25%
EPS Next Y6.25%
EPS Next 2Y21.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.28%
Revenue growth 3Y-2.51%
Revenue growth 5Y-4%
Sales Q2Q%5.89%
Revenue Next Year1.88%
Revenue Next 2Y4.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.31%
EBIT growth 3Y-22.1%
EBIT growth 5Y-22.03%
EBIT Next Year31.04%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.59%
FCF growth 3Y-53.9%
FCF growth 5Y-43.29%
OCF growth 1Y-63.36%
OCF growth 3Y-40.08%
OCF growth 5Y-32.58%

USANA HEALTH SCIENCES INC / USNA Fundamental Analysis FAQ

What is the fundamental rating for USNA stock?

ChartMill assigns a fundamental rating of 6 / 10 to USNA.


Can you provide the valuation status for USANA HEALTH SCIENCES INC?

ChartMill assigns a valuation rating of 7 / 10 to USANA HEALTH SCIENCES INC (USNA). This can be considered as Undervalued.


What is the profitability of USNA stock?

USANA HEALTH SCIENCES INC (USNA) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for USNA stock?

The Price/Earnings (PE) ratio for USANA HEALTH SCIENCES INC (USNA) is 9.64 and the Price/Book (PB) ratio is 0.64.


What is the expected EPS growth for USANA HEALTH SCIENCES INC (USNA) stock?

The Earnings per Share (EPS) of USANA HEALTH SCIENCES INC (USNA) is expected to grow by 6.25% in the next year.